COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 197 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $251,884 | -42.1% | 11,270 | -44.3% | 0.00% | – |
Q2 2023 | $434,915 | +19.6% | 20,238 | +33.5% | 0.00% | – |
Q1 2023 | $363,545 | +355.7% | 15,154 | +340.7% | 0.00% | – |
Q4 2022 | $79,785 | +10.8% | 3,439 | -23.9% | 0.00% | – |
Q3 2022 | $72,000 | -14.3% | 4,518 | -4.9% | 0.00% | – |
Q2 2022 | $84,000 | -94.3% | 4,751 | -93.4% | 0.00% | – |
Q1 2022 | $1,474,000 | -14.4% | 72,395 | -21.4% | 0.00% | – |
Q4 2021 | $1,721,000 | -34.5% | 92,091 | -30.8% | 0.00% | -100.0% |
Q3 2021 | $2,626,000 | -12.3% | 133,006 | +5.0% | 0.00% | 0.0% |
Q2 2021 | $2,995,000 | -11.4% | 126,698 | -11.2% | 0.00% | 0.0% |
Q1 2021 | $3,381,000 | +53.5% | 142,598 | +29.6% | 0.00% | 0.0% |
Q4 2020 | $2,203,000 | +2.9% | 110,013 | +7.0% | 0.00% | 0.0% |
Q3 2020 | $2,140,000 | +37.1% | 102,793 | +15.3% | 0.00% | – |
Q2 2020 | $1,561,000 | +25.8% | 89,190 | +17.4% | 0.00% | – |
Q1 2020 | $1,241,000 | -4.6% | 75,963 | +20.2% | 0.00% | – |
Q4 2019 | $1,301,000 | +97.4% | 63,185 | +10.2% | 0.00% | – |
Q3 2019 | $659,000 | -2.9% | 57,346 | +11.0% | 0.00% | – |
Q2 2019 | $679,000 | -26.8% | 51,649 | -15.6% | 0.00% | – |
Q1 2019 | $927,000 | -32.7% | 61,174 | -23.8% | 0.00% | – |
Q4 2018 | $1,377,000 | +86.3% | 80,270 | +60.1% | 0.00% | – |
Q3 2018 | $739,000 | +77.6% | 50,135 | +187.7% | 0.00% | – |
Q2 2018 | $416,000 | -11.5% | 17,429 | -5.3% | 0.00% | – |
Q1 2018 | $470,000 | -29.9% | 18,406 | -73.8% | 0.00% | – |
Q4 2017 | $670,000 | +41.1% | 70,359 | +55.5% | 0.00% | – |
Q3 2017 | $475,000 | -5.4% | 45,254 | +12.8% | 0.00% | – |
Q2 2017 | $502,000 | -42.5% | 40,118 | -53.8% | 0.00% | – |
Q1 2017 | $873,000 | +225.7% | 86,776 | +404.1% | 0.00% | – |
Q4 2016 | $268,000 | +56.7% | 17,213 | +94.2% | 0.00% | – |
Q3 2016 | $171,000 | +612.5% | 8,865 | +350.5% | 0.00% | – |
Q2 2016 | $24,000 | -80.8% | 1,968 | -71.3% | 0.00% | – |
Q1 2016 | $125,000 | -20.4% | 6,847 | +20.1% | 0.00% | – |
Q4 2015 | $157,000 | +15600.0% | 5,701 | +17175.8% | 0.00% | – |
Q3 2015 | $1,000 | -83.3% | 33 | -90.1% | 0.00% | – |
Q2 2015 | $6,000 | – | 334 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |